<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The link between <z:e sem="disease" ids="C0149678" disease_type="Disease or Syndrome" abbrv="">EBV infection</z:e> and Burkitt <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e>) is strong, but the mechanism underlying that link has been elusive </plain></SENT>
<SENT sid="1" pm="."><plain>We have developed a mouse model for EBV-associated <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> in which LMP2A, an EBV latency protein, and MYC are expressed in B cells </plain></SENT>
<SENT sid="2" pm="."><plain>Our model has demonstrated the ability of LMP2A to accelerate <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> <z:hpo ids='HP_0003674'>onset</z:hpo>, increase spleen size, and bypass p53 inactivation </plain></SENT>
<SENT sid="3" pm="."><plain>Here we describe the results of total gene expression analysis of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> and pretumor B cells from our transgenic mouse model </plain></SENT>
<SENT sid="4" pm="."><plain>Although we see many phenotypic differences and changes in gene expression in pretumor B cells, the transcriptional profiles of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cells from LMP2A/λ-MYC and λ-MYC mice are strikingly similar, with fewer than 20 genes differentially expressed </plain></SENT>
<SENT sid="5" pm="."><plain>We evaluated the functional significance of one of the most interesting differentially expressed genes, Egr1, and found that it was not required for acceleration of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> <z:hpo ids='HP_0003674'>onset</z:hpo> by LMP2A </plain></SENT>
<SENT sid="6" pm="."><plain>Our studies demonstrate the remarkable ability of LMP2A to affect the pretumor B-<z:mp ids='MP_0005384'>cell phenotype</z:mp> and <z:mp ids='MP_0002006'>tumorigenesis</z:mp> without substantially altering gene expression in <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cells </plain></SENT>
</text></document>